JPMorgan Chase & Co’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Buy |
32,790
+8,581
| +35% | +$102K | ﹤0.01% | 4168 |
|
|
2025
Q1 | $288K | Buy |
24,209
+23,661
| +4,318% | +$281K | ﹤0.01% | 4292 |
|
|
2024
Q4 | $8.43K | Sell |
548
-9,222
| -94% | -$142K | ﹤0.01% | 5379 |
|
|
2024
Q3 | $110K | Buy |
9,770
+3,612
| +59% | +$40.5K | ﹤0.01% | 4685 |
|
|
2024
Q2 | $33.2K | Sell |
6,158
-9,694
| -61% | -$52.3K | ﹤0.01% | 5030 |
|
|
2024
Q1 | $108K | Sell |
15,852
-15,570
| -50% | -$106K | ﹤0.01% | 4702 |
|
|
2023
Q4 | $213K | Sell |
31,422
-10,382
| -25% | -$70.5K | ﹤0.01% | 4419 |
|
|
2023
Q3 | $209K | Sell |
41,804
-8,770
| -17% | -$43.9K | ﹤0.01% | 4214 |
|
|
2023
Q2 | $366K | Buy |
50,574
+14,356
| +40% | +$104K | ﹤0.01% | 3928 |
|
|
2023
Q1 | $306K | Buy |
36,218
+1,719
| +5% | +$14.5K | ﹤0.01% | 4082 |
|
|
2022
Q4 | $292K | Buy |
34,499
+1,693
| +5% | +$14.3K | ﹤0.01% | 4029 |
|
|
2022
Q3 | $340K | Sell |
32,806
-698
| -2% | -$7.23K | ﹤0.01% | 3934 |
|
|
2022
Q2 | $437K | Sell |
33,504
-23,855
| -42% | -$311K | ﹤0.01% | 3954 |
|
|
2022
Q1 | $597K | Buy |
57,359
+4,726
| +9% | +$49.2K | ﹤0.01% | 3906 |
|
|
2021
Q4 | $590K | Buy |
52,633
+1,413
| +3% | +$15.8K | ﹤0.01% | 3966 |
|
|
2021
Q3 | $910K | Sell |
51,220
-1,650
| -3% | -$29.3K | ﹤0.01% | 3670 |
|
|
2021
Q2 | $1.01M | Buy |
52,870
+9,050
| +21% | +$173K | ﹤0.01% | 3622 |
|
|
2021
Q1 | $926K | Buy |
43,820
+2,493
| +6% | +$52.7K | ﹤0.01% | 3700 |
|
|
2020
Q4 | $657K | Buy |
41,327
+39,819
| +2,641% | +$633K | ﹤0.01% | 3609 |
|
|
2020
Q3 | $9K | Hold |
1,508
| – | – | ﹤0.01% | 4600 |
|
|
2020
Q2 | $5K | Buy |
1,508
+8
| +0.5% | +$27 | ﹤0.01% | 4556 |
|
|
2020
Q1 | $5K | Sell |
1,500
-1,500
| -50% | -$5K | ﹤0.01% | 4520 |
|
|
2019
Q4 | $14K | Hold |
3,000
| – | – | ﹤0.01% | 4458 |
|
|
2019
Q3 | $15K | Buy |
+3,000
| New | +$15K | ﹤0.01% | 4518 |
|